Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts

AIMS: Despite the lower patency of venous compared with arterial coronary artery bypass grafts, ∼50% of grafts used are saphenous vein conduits because of their easier accessibility. In a search for ways to increase venous graft patency, we applied the results of a previous pharmacological study scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Reisinger, Ute, Schwaiger, Stefan, Zeller, Iris, Messner, Barbara, Stigler, Robert, Wiedemann, Dominik, Mayr, Tobias, Seger, Christoph, Schachner, Thomas, Dirsch, Verena M., Vollmar, Angelika M., Bonatti, Johannes O., Stuppner, Hermann, Laufer, Günther, Bernhard, David
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682615/
https://www.ncbi.nlm.nih.gov/pubmed/19228707
http://dx.doi.org/10.1093/cvr/cvp059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682615/
https://www.ncbi.nlm.nih.gov/pubmed/19228707
http://dx.doi.org/10.1093/cvr/cvp059

Ejemplares similares